Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs NuviaRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and NuviaRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 131 · Grade C

NuviaRx

Visit NuviaRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make NuviaRx a bad call — it's best for readers comparing annual-plan offers who can obtain the full payment schedule and unused-plan refund terms before ordering. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
74
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
82
Track Record
88
73
CoreAge RxBrief Score 94 · 72NuviaRx

Price, coverage & the tracker

CoreAge RxNuviaRx
Brief Score94/100 (A)72/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm annual-plan total

Advertised $140/mo requires an annual plan; full charge, payment schedule and unused-balance terms need confirmation.

Full price details

Compounded semaglutide offered; current annual-plan payment schedule and complete quote unknown; earlier listing: From $140/mo (all doses, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm annual-plan total

Advertised $170/mo requires an annual plan; full charge, payment schedule and unused-balance terms need confirmation.

Full price details

Compounded tirzepatide offered; current annual-plan payment schedule and complete quote unknown; earlier listing: From $170/mo (all doses, compounded)

CoverageUS only; restrictions by state, confirmed at intakeUS service with medication-specific state restrictions; confirm eligibility for your location
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

NuviaRx: The $140 semaglutide and $170 tirzepatide figures require an annual plan. Full upfront charges and payment schedules remain unconfirmed; earlier prices retain their historical date.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.